Literature DB >> 24060532

Deep brain stimulation in dementia-related disorders.

Sarah Hescham1, Lee Wei Lim, Ali Jahanshahi, Arjan Blokland, Yasin Temel.   

Abstract

Memory loss is the key symptom of dementia-related disorders, including the prevalent Alzheimer's disease (AD). To date, pharmacological treatments for AD have limited and short-lasting effects. Therefore, researchers are investigating novel therapies such as deep brain stimulation (DBS) to treat memory impairment and to reduce or stop the progression of it. Clinical and preclinical studies have been performed and stimulations of the fornix, entorhinal cortex and nucleus basalis of Meynert have been carried out. The results of these studies suggest that DBS has the potential to enhance memory functions in patients and animal models. The mechanisms underlying memory enhancement may include the release of specific neurotransmitters and neuroplasticity. Some authors suggest that DBS might even be disease-modifying. Nevertheless, it is still premature to conclude that DBS can be used in the treatment of AD, and the field will wait for the results of ongoing clinical trials.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Deep brain stimulation; Dementia; Entorhinal cortex; Fornix; Hippocampus; Limbic system; Memory; Neuroanatomy; Nucleus basalis of Meynert; Papez circuit

Mesh:

Year:  2013        PMID: 24060532     DOI: 10.1016/j.neubiorev.2013.09.002

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  17 in total

Review 1.  Neurostimulation in Alzheimer's disease: from basic research to clinical applications.

Authors:  Raffaele Nardone; Yvonne Höller; Frediano Tezzon; Monica Christova; Kerstin Schwenker; Stefan Golaszewski; Eugen Trinka; Francesco Brigo
Journal:  Neurol Sci       Date:  2015-02-27       Impact factor: 3.307

2.  The Emerging Role of Biomarkers in Adaptive Modulation of Clinical Brain Stimulation.

Authors:  Kimberly B Hoang; Dennis A Turner
Journal:  Neurosurgery       Date:  2019-09-01       Impact factor: 4.654

Review 3.  Cognition in movement disorders: where can we hope to be in ten years?

Authors:  David Burn; Daniel Weintraub; Bernard Ravina; Irene Litvan
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 4.  A Novel Explainability Approach for Technology-Driven Translational Research on Brain Aging.

Authors:  Adam Turnbull; Robert M Kaplan; Ehsan Adeli; Feng V Lin
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 5.  Optogenetic Dissection of the Basal Forebrain Neuromodulatory Control of Cortical Activation, Plasticity, and Cognition.

Authors:  Shih-Chieh Lin; Ritchie E Brown; Marshall G Hussain Shuler; Carl C H Petersen; Adam Kepecs
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

6.  Deep Brain Stimulation in Epilepsy: A Role for Modulation of the Mammillothalamic Tract in Seizure Control?

Authors:  Frédéric L W V J Schaper; Birgit R Plantinga; Albert J Colon; G Louis Wagner; Paul Boon; Nadia Blom; Erik D Gommer; Govert Hoogland; Linda Ackermans; Rob P W Rouhl; Yasin Temel
Journal:  Neurosurgery       Date:  2020-09-01       Impact factor: 4.654

7.  A frontal cortex event-related potential driven by the basal forebrain.

Authors:  David P Nguyen; Shih-Chieh Lin
Journal:  Elife       Date:  2014-01-01       Impact factor: 8.140

8.  Behavioral effects of deep brain stimulation of the anterior nucleus of thalamus, entorhinal cortex and fornix in a rat model of Alzheimer's disease.

Authors:  Chao Zhang; Wen-Han Hu; De-Long Wu; Kai Zhang; Jian-Guo Zhang
Journal:  Chin Med J (Engl)       Date:  2015-05-05       Impact factor: 2.628

Review 9.  Technology for deep brain stimulation at a gallop.

Authors:  Alberto Priori
Journal:  Mov Disord       Date:  2015-05-23       Impact factor: 10.338

10.  Ventromedial prefrontal cortex stimulation enhances memory and hippocampal neurogenesis in the middle-aged rats.

Authors:  Albert Liu; Neeraj Jain; Ajai Vyas; Lee Wei Lim
Journal:  Elife       Date:  2015-03-13       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.